“This patent secures Zelegent’s position in the development of advanced, minimally invasive devices for the sleep specialist otolaryngology community to offer patients a novel, minimally-invasive, office based procedure that requires no general anesthesia, and that may alleviate snoring by shortening, suspending, and stiffening a patient’s soft palate,” said Alexander K. Arrow, M.D., CEO of Zelegent.
A Premarket Notification for the Zelegent Inc. Elevo Kit, which was evaluated in the multi-center S.I.LE.N.C.E. Study, is under review by the U.S. Food and Drug Administration.
Zelegent Inc. (formerly Snorx Inc.), is a medical technology company developing tools for physicians who treat sleep disorders. The company’s mission is to develop and provide minimally invasive devices to treat snoring. Elevoplasty is a patented, office-based procedure. The Elevo Kit is an investigational device only and is not for sale in the United States.
Zelegent and Silence is Healthy are trademarks of Zelegent Inc. Zelegent is part of the EvoNexus family of companies.